SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-15-004707
Filing Date
2015-06-24
Accepted
2015-06-24 13:20:06
Documents
3
Period of Report
2015-06-24

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER f6k062415_biondvaxpharma.htm 6-K 15037
2 PRESS RELEASE, DATED JUNE 24, 2015 f6k062415ex99i_biondvax.htm EX-99.1 10866
3 GRAPHIC logo.jpg GRAPHIC 16706
  Complete submission text file 0001213900-15-004707.txt   50042
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 15948805
SIC: 2836 Biological Products, (No Diagnostic Substances)